CTNNBL1rs6013029 | n (men/women) | Genotype distribution nGG/GT/TT (%) | MAF (95% CI) | p add | p dom | ORadd (95% CI) |
---|---|---|---|---|---|---|
Controls | 5,190 (2,271/3,019) | 4,740/444/6 (91.4/8.5/0.1) | 4.4 (4.0–4.8) | |||
Overweight cases | 7,229 (4,496/2,733) | 6,589/629//11 (91.1/8.7/0.2) | 4.5 (4.2–4.9) | 0.7 | 0.8 | 1.02 (0.90–1.16) |
Obese cases | 4,928 (2,543/2,385) | 4,464/456/8 (90.5/9.3/0.2) | 4.8 (4.4–5.2) | 0.2 | 0.2 | 1.09 (0.95–1.25) |
Morbid obese cases | 399 (135/264) | 356/43/0 (89.1/10.9/0.0) | 5.4 (3.9–7.2) | 0.2 | 0.1 | 1.26 (0.91–1.74) |
CTNNBL1 rs6020846 | n (men/women) | Genotype distribution n AA/GA/GG (%) | MAF (95% CI) | p add | p dom | OR add (95% CI) |
Controls | 5,188 (2,169/3,019) | 4,673/504/11 (90.1/9.7/0.2) | 5.1 (4.7–5.5) | |||
Overweight cases | 7,204 (4,492/2,712) | 6,448/738/18 (89.4/10.3/0.2) | 5.4 (5.0–5.8) | 0.5 | 0.5 | 1.05 (0.93–1.18) |
Obese cases | 4,905 (2,533/2,372) | 4,358/531/16 (88.8/10.9/0.3) | 5.7 (5.3–6.2) | 0.06 | 0.06 | 1.13 (1.00–1.28) |
Morbid obese cases | 394 (134/260) | 348/46/0 (88.2/11.8/0.0) | 5.8 (4.3–7.7) | 0.3 | 0.2 | 1.17 (0.86–1.61) |
FDFT1 rs7001819 | n (men/women) | Genotype distribution n TT/TC/CC (%) | MAF (95% CI) | p add | p dom | OR add (95% CI) |
Controls | 5,089 (2,123/2,966) | 2,084/2,367/638 (40.9/46.5/12.6) | 35.8 (34.9–36.7) | |||
Overweight cases | 7,078 (4,391/2,687) | 2,843/3,281/954 (40.2/46.3/13.5) | 36.7 (35.9–37.5) | 0.5 | 0.6 | 1.02 (0.97–1.08) |
Obese cases | 4,810 (2,491/2,319) | 1,963/2,258/589 (40.6/47.1/12.3) | 35.7 (34.8–36.7) | 0.6 | 0.9 | 0.99 (0.93–1.05) |
Morbid obese cases | 387 (131/256) | 158/184/45 (41.0/47.5/11.5) | 35.4 (32.0–38.9) | 0.9 | 0.9 | 0.99 (0.85–1.16) |